Predictive Oncology Says Subsidiaries Soluable Biotech, TumorGenesis Both Constructing New GMP Labs
Predictive Oncology (NASDAQ:POAI), an AI-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries, Soluble Biotech Inc. and TumorGenesis Inc. are both expanding their unique